4.7 Article

Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Anatomy & Morphology

Clinical Impact of the Epithelial-Mesenchymal Transition in Lung Cancer as a Biomarker Assisting in Therapeutic Decisions

Julien Ancel et al.

Summary: The paper reviews the clinical and histological features of non-small-cell lung cancer associated with EMT and explores the potential clinical implications of EMT in lung cancer treatment.

CELLS TISSUES ORGANS (2022)

Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Article Oncology

MiR-205-5p promotes lung cancer progression and is valuable for the diagnosis of lung cancer

Yu-Long Zhao et al.

Summary: miR-205-5p promotes cell proliferation and metastasis in lung cancer by negatively regulating the target gene TP53INP1, which further affects the expression of P21, RB1, and cyclin D1. Serum miR-205-5p is a valuable biomarker for lung cancer diagnosis.

THORACIC CANCER (2022)

Article Oncology

Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas

Radu Pirlog et al.

Summary: Lung adenocarcinoma is the most common subtype of lung cancer, and the KRAS gene mutation is a frequent genomic alteration in these tumors. New clinical trials using targeted inhibitors for the specific KRAS G12C mutation showed promising results in a significant proportion of cases. In this study, genomic analysis was performed to identify molecular subtypes that may be more susceptible to therapy with KRAS G12C inhibitors.

CANCERS (2022)

Article Cardiac & Cardiovascular Systems

Prognostic impact of tumor-infiltrating lymphocytes in non-small cell lung carcinomas

Mona Mlika et al.

Summary: This study confirms the prognostic value of tumor-infiltrating lymphocytes in non-small cell lung carcinomas and highlights the importance of quantifying their different subpopulations. Factors such as CD8/CD4 ratio were found to be independent predictors of overall survival, recurrence-free survival, and relapse-free survival.

ASIAN CARDIOVASCULAR & THORACIC ANNALS (2022)

Review Medicine, General & Internal

Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Ryota Ushio et al.

Summary: Immune checkpoint inhibitors (ICIs) have significantly improved the outcomes of non-small cell lung cancer patients. However, there is a lack of predictive biomarkers other than tumor PD-L1 expression. The search for biomarkers is urgent, and various biomarkers including PD-L1, tumor mutation burden, and blood biomarkers such as peripheral T-cell phenotype, neutrophil-to-lymphocyte ratio, interferon-gamma, and interleukin-8 have been identified. The development of composite markers and novel technologies may enable comprehensive analysis of multiple biomarkers.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Critical Care Medicine

Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial

David S. Gierada et al.

Summary: The study found that low-dose CT screening can improve the survival rate of stage I lung cancer, especially for smaller primary tumor size and surgical treatment.
Review Medicine, Research & Experimental

Mechanisms of small cell lung cancer metastasis

Julie Ko et al.

Summary: Metastasis is a major cause of morbidity and mortality in cancer patients, especially with small cell lung cancer (SCLC) known for its remarkable metastatic proclivity. Recent advances in research, such as using circulating tumor cells and genetically engineered mouse models, are helping to overcome limitations in studying SCLC metastasis. New insights into cellular mechanisms associated with increased metastatic ability offer promise for future therapeutic options.

EMBO MOLECULAR MEDICINE (2021)

Article Oncology

Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma

Chengde Wu et al.

Summary: The study focused on the impact of TP53 mutation on the immune landscape of early-stage LUAD and developed an immune prognostic model (IPM) based on TP53 status to predict prognosis accurately.Results showed that TP53 mutation influenced the immune response in LUAD, with the IPM being a reliable tool to identify high-risk patients for unfavorable survival outcomes.

CANCER MEDICINE (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Biochemistry & Molecular Biology

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer

Sara Elena Rebuzzi et al.

Summary: In the systemic treatment of advanced NSCLC patients, targeted therapies such as EGFR, ALK, ROS1, and BRAF inhibitors have been significant breakthroughs. In addition to these known molecular drivers, potential therapeutic targets including MET, RET, NTRK, KRAS, PIK3CA, and HER2 are rapidly emerging. Research on these emerging molecular targets is crucial to increasing the proportion of patients benefiting from tailored therapeutic approaches.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Genetics & Heredity

Single-cell RNA sequencing for the identification of early-stage lung cancer biomarkers from circulating blood

Jinhong Kim et al.

Summary: Markers of early-stage lung cancer were identified through single-cell RNA sequencing analysis and validated in primary lung tumors and circulating blood.

NPJ GENOMIC MEDICINE (2021)

Review Medical Laboratory Technology

miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer

Shen Zhong et al.

Summary: Blood-borne miR-20a, miR-10b, miR-150, and miR-223 were identified as excellent diagnostic biomarkers for non-small cell lung cancer, while miR205 showed specificity for squamous cell carcinoma. Additionally, a systematic review revealed 38 commonly regulated miRNAs in tumor tissue and circulation, enabling the prediction of histological subtypes of LC.

TRANSLATIONAL RESEARCH (2021)

Review Oncology

Therapeutic Targeting of the Tumor Microenvironment

Leire Bejarano et al.

Summary: This review provides a comprehensive analysis of the current therapies targeting the TME, combining a discussion of the underlying basic biology with clinical evaluation of different therapeutic approaches, and highlighting the challenges and future perspectives.

CANCER DISCOVERY (2021)

Review Pharmacology & Pharmacy

The Role of Tumor Inflammatory Microenvironment in Lung Cancer

Zhaofeng Tan et al.

Summary: Lung cancer is the most common and fatal malignant tumor globally, with inflammation playing a crucial role in its occurrence and development. Inflammatory cells and factors in the tumor microenvironment promote lung cancer by activating inflammatory pathways and mechanisms like immune escape, angiogenesis, and apoptosis. Understanding the relationship between inflammation and lung cancer through the tumor microenvironment can lead to the discovery of new therapeutic targets for the disease.

FRONTIERS IN PHARMACOLOGY (2021)

Editorial Material Biochemistry & Molecular Biology

Tumor-infiltrating lymphocytes make inroads in non-small-cell lung cancer

Joshua R. Veatch et al.

Summary: Preliminary results from a phase 1 trial suggest promising anti-tumor activity of tumor-infiltrating-lymphocyte therapy in patients with advanced non-small-cell lung cancer.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

Tertiary lymphoid structures (TLS) identification and density assessment on H&E-stained digital slides of lung cancer

Panagiotis Barmpoutis et al.

Summary: This study introduces a new method for automated identification and quantification of TLS on H&E tissue slides, with mathematical criteria defining TLS and utilizing deep learning networks and an ellipsoidal model for segmentation. The research shows that the density of lymphocytes within TLS regions is more than 3 times that of non-TLS regions.

PLOS ONE (2021)

Article Cell Biology

Comprehensive Analysis of a Nine-Gene Signature Related to Tumor Microenvironment in Lung Adenocarcinoma

Haihui Zhong et al.

Summary: The study identified a prognostic risk model consisting of nine hub genes for LUAD, with high-risk patients having poor prognoses. The model serves as an independent prognostic factor for LUAD patients, and a nomogram was developed for prognostic prediction.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Cell Biology

miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis

Dong Pan et al.

Summary: This study investigated the effects of miR-29b-3p on the radiosensitivity of 3D cultured stem-like cells, finding that its downregulation increased radioresistance, while high expression showed advantages in patient prognosis.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Cell Biology

Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma

Youyu Wang et al.

Summary: This study revealed immunological heterogeneity in the TME of patients with LUAD, showing different ratios of immune cells and stromal cells, different functions, and varying degrees of activation of immune-related pathways in different tumor parts.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biotechnology & Applied Microbiology

MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route

Butong Sun et al.

Summary: The research found that miR-25-3p plays a crucial role in cisplatin resistance in NSCLC, accelerating drug tolerance by regulating the PTEN/PI3K/AKT signaling pathway.

BIOENGINEERED (2021)

Article Oncology

Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies

N. Jacquelot et al.

Summary: Tertiary lymphoid structures (TLS) are ectopic cellular aggregates resembling secondary lymphoid organs. Found in solid tumors, TLS exhibit varying degrees of maturation and are composed of diverse immune cell types that actively drive the immune response against tumor development and progression. Their role, prognostic value, and potential for immunotherapeutic targeting are discussed in this review.

ONCOIMMUNOLOGY (2021)

Review Oncology

P120 and E-cadherin: Double-edged swords in tumor metastasis

Jan-Hendrik Venhuizen et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Biotechnology & Applied Microbiology

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer

Guo-Chen Duan et al.

ONCOTARGETS AND THERAPY (2020)

Review Immunology

Tertiary lymphoid structures in cancer - considerations for patient prognosis

Luis Munoz-Erazo et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Review Cell Biology

Guidelines and definitions for research on epithelial-mesenchymal transition

Jing Yang et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Biotechnology & Applied Microbiology

Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis

Wei-Xiao Xue et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Oncology

Lung Cancer and Immunity Markers

Raymond J. Lim et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Review Oncology

Epithelial-Mesenchymal Transition in Cancer: A Historical Overview

Domenico Ribatti et al.

TRANSLATIONAL ONCOLOGY (2020)

Article Medicine, General & Internal

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

David S. Hong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Biochemistry & Molecular Biology

The Roles of MicroRNA in Lung Cancer

Kuan-Li Wu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung Cancer

Shaun M. O'Brien et al.

CANCER IMMUNOLOGY RESEARCH (2019)

Review Genetics & Heredity

Circulating MicroRNAs in Cancer: Potential and Challenge

Mengying Cui et al.

FRONTIERS IN GENETICS (2019)

Article Oncology

Cancer Progress and Priorities: Lung Cancer

Matthew B. Schabath et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)

Review Cell Biology

An overview of microRNAs: Biology, functions, therapeutics, and analysis methods

Kioomars Saliminejad et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Oncology

miR-181a/b therapy in lung cancer: reality or myth?

Cornelia Braicu et al.

MOLECULAR ONCOLOGY (2019)

Article Medicine, General & Internal

Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer

Paola Ulivi et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Oncology

Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients

Cherylle Goebel et al.

CANCER GENOMICS & PROTEOMICS (2019)

Article Oncology

Ectopic Expression of miRNA-21 and miRNA-205 in Non-Small Cell Lung Cancer

Seyedeh Afrooz Azimi et al.

INTERNATIONAL JOURNAL OF CANCER MANAGEMENT (2019)

Review Oncology

MiR-181 family-specific behavior in different cancers: a meta-analysis view

Cecilia Pop-Bica et al.

CANCER AND METASTASIS REVIEWS (2018)

Review Respiratory System

miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC)

Yichao Han et al.

JOURNAL OF THORACIC DISEASE (2018)

Review Biochemistry & Molecular Biology

How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?

Brandon J. Aubrey et al.

CELL DEATH AND DIFFERENTIATION (2018)

Review Pharmacology & Pharmacy

Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies

Xiaohong Du et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Article Multidisciplinary Sciences

Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles

Srinivasulu Yerukala Sathipati et al.

SCIENTIFIC REPORTS (2017)

Article Biochemistry & Molecular Biology

miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis

Yannan Fan et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Respiratory System

Tumor infiltrating lymphocytes in lung cancer: a new prognostic parameter

Kobe Reynders et al.

JOURNAL OF THORACIC DISEASE (2016)

Review Biochemistry & Molecular Biology

The role of MicroRNAs in human cancer

Yong Peng et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)

Article Cell Biology

Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis

Yiting Geng et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)

Article Multidisciplinary Sciences

Comprehensive genomic profiles of small cell lung cancer

Julie George et al.

NATURE (2015)

Article Biochemistry & Molecular Biology

DIANA-miRPath v3.0: deciphering microRNA function with experimental support

Ioannis S. Vlachos et al.

NUCLEIC ACIDS RESEARCH (2015)

Review Biotechnology & Applied Microbiology

The role of miR-29b in cancer: regulation, function, and signaling

Bin Yan et al.

ONCOTARGETS AND THERAPY (2015)

Article Critical Care Medicine

Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

Claire Germain et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Article Multidisciplinary Sciences

Comprehensive molecular profiling of lung adenocarcinoma

Eric A. Collisson et al.

NATURE (2014)

Article Oncology

Diverse roles of miR-29 in cancer (Review)

Hesong Jiang et al.

ONCOLOGY REPORTS (2014)

Article Oncology

MicroRNAs as lung cancer biomarkers

Valerio Del Vescovo et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)

Article Multidisciplinary Sciences

Comprehensive genomic characterization of squamous cell lung cancers

Peter S. Hammerman et al.

NATURE (2012)

Article Biochemistry & Molecular Biology

MicroRNA: Biogenesis, Function and Role in Cancer

Leigh-Ann MacFarlane et al.

CURRENT GENOMICS (2010)